1 Min Read
QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding to drive innovation in brain cancer. QV has created an implantable device – the first of its kind globally – designed to improve outcomes in hard-to-treat glioblastoma (GBM). QV’s implant technology is known as Glioma […] The post QV Bioelectronics secures £4.5m in funding for brain cancer therapy development appeared first on Pharmafile.
Work & Theory on February 3, 2026
Uncategorized